Devices, methods, and systems of functional optical coherence tomography

Patent metadata

Field	Value
Publication number	US-9962075-B2
Application number	US-201715465285-A
Country	US
Kind code	B2
Filing date	Mar 21, 2017
Priority date	Apr 28, 2014
Publication date	May 8, 2018
Grant date	May 8, 2018

Abstract

The present disclosure provides systems and methods for the determining a rate of change of one or more analyte concentrations in a target using non invasive non contact imaging techniques such as OCT. Generally, OCT data is acquired and optical information is extracted from OCT scans to quantitatively determine both a flow rate of fluid in the target and a concentration of one or more analytes. Both calculations can provide a means to determine a change in rate of an analyte over time. Example methods and systems of the disclosure may be used in assessing metabolism of a tissue, where oxygen is the analyte detected, or other functional states, and be generally used for the diagnosis, monitoring and treatment of disease.

First claim

What is claimed is:

1. A method for imaging a target, the method comprising:
a. performing optical coherence tomography (OCT) scanning on a target with one or more beams of low coherence light, wherein the one or more beams of low coherence light comprise one or more wavelengths and the one or more beams of light are used to perform a single measurement;
b. acquiring optical information from reflected signals generated by the performed OCT scanning in the single measurement;
c. quantitatively three dimensional (3D) imaging the target in the single measurement using at least one of visible light or invisible light;
d. concurrently determining a flow rate of a fluid in the target and a concentration of one or more analytes in the fluid from the acquired optical information and the quantitative 3D imaging in the single measurement;
e. determining a rate of change of the one or more analyte concentrations in the target based on the determining of flow rate of a fluid and a concentration of one or more analytes, wherein a medical decision is made by determining the rate of change of the one or more analyte concentrations in the target.

2. The method of claim 1 , wherein the OCT scanning on the target is performed with identical or different pre-defined scanning trajectories.

3. The method of claim 1 , wherein the target is selected from the group consisting of tissue, healthy tissue, diseased tissue, retina, tumor, cancer, growth, fibroid, lesion, skin, mucosal lining, organ, graft, blood supply and one or more blood vessels.

4. The method of claim 1 , wherein the fluid is selected from the group consisting of whole blood, blood plasma, blood serum, urine, semen, tears, sweat, saliva, lymph fluid, pleural effusion, peritoneal fluid, meningal fluid, amniotic fluid, glandular fluid, spinal fluid, conjunctival fluid, vitreous, aqueous, vaginal fluid, bile, mucus, sputum and cerebrospinal fluid.

5. The method of claim 1 , wherein the analyte is selected from the group consisting of oxygen, hemoglobin, oxygenated hemoglobin, deoxygenated hemoglobin, glucose, sugar, blood area nitrogen, lactate, hematocrit, biomarker and nucleic acid.

6. The method of claim 1 , wherein determining the rate of change of one or more analytes is performed by comparing or using a reference.

7. The method of claim 6 , wherein the reference is healthy tissue.

8. The method of claim 6 , wherein the reference is the target in which the flow rate of a fluid and the concentration of one or more analytes have been previously been quantified.

9. The method of claim 1 , wherein one or more images of the target are generated, wherein the one or more images and the change in rate of analyte concentration are used to calculate a function of the target or a change in the function of the target, and wherein the function of the target is a pathological alteration in a tissue.

10. The method of claim 1 , wherein an exogenous agent is contacted with the target.

11. The method of claim 10 , wherein the exogenous agent is a contrast reagent.

12. The method of claim 1 , wherein the method is configured for a device selected from the group consisting of probe, handheld device, wearable device, endoscope, catheter probe, laparoscopic tool, surgical tool, and needle.

13. The method of claim 1 , wherein the method is configured to screen or optimize one or more drugs, treatment protocols or pharmaceutical reagents.

14. A non-transitory computer readable medium comprising instructions, which, when executed by a processor, implement method for imaging a target, the method comprising:
a. performing optical coherence tomography (OCT) scanning on a target with one or more beams of low coherence light, wherein the one or more beams of low coherence light comprise one or more wavelengths and the one or more beams of light are used to perform a single measurement;
b. acquiring optical information from reflected signals generated by the performed OCT scanning in the single measurement;
c. quantitatively three dimensional (3D) imaging the target in the single measurement using at least one of visible light or invisible light;
d. concurrently determining a flow rate of a fluid in the target and a concentration of one or more analytes in the fluid from the acquired optical information and the quantitative 3D imaging in the single measurement;
e. determining a rate of change of the one or more analyte concentrations in the target based on the determining of flow rate of a fluid and a concentration of one or more analytes, wherein a medical decision is made by determining the rate of change of the one or more analyte concentrations in the target.

15. The non-transitory computer readable medium of claim 14 , wherein the OCT scanning on the target is performed with identical or different pre-defined scanning trajectories.

16. The non-transitory computer readable medium of claim 14 , wherein determining the rate of change of one or more analytes is performed by comparing or using a reference.

17. The non-transitory computer readable medium of claim 16 , wherein the reference is the target in which the flow rate of a fluid and the concentration of one or more analytes have been previously been quantified.

18. The non-transitory computer readable medium of claim 16 , wherein one or more images of the target are generated, wherein the one or more images and the change in rate of analyte concentration are used to calculate a function of the target or a change in the function of the target, and wherein the function of the target is a pathological alteration in a tissue.

19. The non-transitory computer readable medium of claim 14 , wherein an exogenous agent is contacted with the target.

20. The non-transitory computer readable medium of claim 19 , wherein the exogenous agent is a contrast reagent.

Assignees

• Univ Northwestern
• Opticent Inc

Inventors

• Yi Ji
• Liu Wenzhong
• Backman Vadim
• Zhang Hao F
• Patel Kieren J

Classifications

• G06T12/00

  Tomographic reconstruction from projections · CPC title

• A61B1/046

  for infrared imaging · CPC title

• A61B3/1233

  for measuring blood flow, e.g. at the retina · CPC title

• A61B5/14517

  for sweat · CPC title

• A61B5/0261

  using optical means, e.g. infrared light · CPC title